Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1989 Aug;67(4):441–446.

Reversible injury of cultured rat oligodendrocytes by complement.

N J Scolding 1, W A Houston 1, B P Morgan 1, A K Campbell 1, D A Compston 1
PMCID: PMC1385311  PMID: 2767708

Abstract

Rat oligodendrocytes are lysed on exposure to normal homologous serum as a result of classical pathway complement activation and attack in the absence of anti-myelin antibodies. The effect of non-lethal complement attack on oligodendrocytes in vitro was studied by exposing dissociated neonatal rat optic nerve cell cultures to low concentrations of complement alone and also in the presence of oligodendrocyte-specific monoclonal antibodies. Regardless of the mode of complement activation, non-lethal complement attack led to reversible cell injury, recovery following a transient rise in intracellular calcium and fall in ATP in the absence of membrane permeabilization to propidium iodide. A single episode of non-lethal injury had no effect on the ability of oligodendrocytes subsequently to express cell-specific antigens, but repeated episodes had a cumulative effect and ultimately resulted in cell death. Reversible and/or lytic complement-mediated oligodendrocyte injury has implications for the pathogenesis of human and experimental demyelinating diseases.

Full text

PDF
441

Images in this article

444Figure 3
on p.444

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Banik N. L., McAlhaney W. W., Hogan E. L. Calcium-stimulated proteolysis in myelin: evidence for a Ca2+-activated neutral proteinase associated with purified myelin of rat CNS. J Neurochem. 1985 Aug;45(2):581–588. doi: 10.1111/j.1471-4159.1985.tb04026.x. [DOI] [PubMed] [Google Scholar]
  2. Berridge M. J., Irvine R. F. Inositol trisphosphate, a novel second messenger in cellular signal transduction. Nature. 1984 Nov 22;312(5992):315–321. doi: 10.1038/312315a0. [DOI] [PubMed] [Google Scholar]
  3. Biesecker G., Müller-Eberhard H. J. The ninth component of human complement: purification and physicochemical characterization. J Immunol. 1980 Mar;124(3):1291–1296. [PubMed] [Google Scholar]
  4. Blaurock A. E., Yale J. L. Calcium ions trigger the expansion in bistable myelin. Neurosci Lett. 1987 Jan 14;73(2):167–172. doi: 10.1016/0304-3940(87)90012-7. [DOI] [PubMed] [Google Scholar]
  5. Campbell A. K. Extraction, partial purification and properties of obelin, the calcium-activated luminescent protein from the hydroid Obelia geniculata. Biochem J. 1974 Nov;143(2):411–418. doi: 10.1042/bj1430411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Campbell A. K., Hallett M. B., Weeks I. Chemiluminescence as an analytical tool in cell biology and medicine. Methods Biochem Anal. 1985;31:317–416. doi: 10.1002/9780470110522.ch7. [DOI] [PubMed] [Google Scholar]
  7. Carney D. F., Hammer C. H., Shin M. L. Elimination of terminal complement complexes in the plasma membrane of nucleated cells: influence of extracellular Ca2+ and association with cellular Ca2+. J Immunol. 1986 Jul 1;137(1):263–270. [PubMed] [Google Scholar]
  8. Compston D. A., Morgan B. P., Oleesky D., Fifield R., Campbell A. K. Cerebrospinal fluid C9 in demyelinating disease. Neurology. 1986 Nov;36(11):1503–1506. doi: 10.1212/wnl.36.11.1503. [DOI] [PubMed] [Google Scholar]
  9. DeLuca M., McElroy W. D. Kinetics of the firefly luciferase catalyzed reactions. Biochemistry. 1974 Feb 26;13(5):921–925. doi: 10.1021/bi00702a015. [DOI] [PubMed] [Google Scholar]
  10. Einstein E. R., Csejtey J., Dalal K. B., Adams C. W., Bayliss O. B., Hallpike J. F. Proteolytic activity and basic protein loss in and around multiple sclerosis plaques: combined biochemical and histochemical observations. J Neurochem. 1972 Mar;19(3):653–662. doi: 10.1111/j.1471-4159.1972.tb01382.x. [DOI] [PubMed] [Google Scholar]
  11. Imagawa D. K., Osifchin N. E., Paznekas W. A., Shin M. L., Mayer M. M. Consequences of cell membrane attack by complement: release of arachidonate and formation of inflammatory derivatives. Proc Natl Acad Sci U S A. 1983 Nov;80(21):6647–6651. doi: 10.1073/pnas.80.21.6647. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Linnington C., Webb M., Woodhams P. L. A novel myelin-associated glycoprotein defined by a mouse monoclonal antibody. J Neuroimmunol. 1984 Sep-Oct;6(6):387–396. doi: 10.1016/0165-5728(84)90064-x. [DOI] [PubMed] [Google Scholar]
  13. Ludwin S. K. Remyelination in the central nervous system and the peripheral nervous system. Adv Neurol. 1988;47:215–254. [PubMed] [Google Scholar]
  14. Morgan B. P., Campbell A. K. The recovery of human polymorphonuclear leucocytes from sublytic complement attack is mediated by changes in intracellular free calcium. Biochem J. 1985 Oct 1;231(1):205–208. doi: 10.1042/bj2310205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Morgan B. P., Daniels R. H., Watts M. J., Williams B. D. In vivo and in vitro evidence of cell recovery from complement attack in rheumatoid synovium. Clin Exp Immunol. 1988 Sep;73(3):467–472. [PMC free article] [PubMed] [Google Scholar]
  16. Morgan B. P., Dankert J. R., Esser A. F. Recovery of human neutrophils from complement attack: removal of the membrane attack complex by endocytosis and exocytosis. J Immunol. 1987 Jan 1;138(1):246–253. [PubMed] [Google Scholar]
  17. Murray N., Steck A. J. Impulse conduction regulates myelin basic protein phosphorylation in rat optic nerve. J Neurochem. 1984 Jul;43(1):243–248. doi: 10.1111/j.1471-4159.1984.tb06702.x. [DOI] [PubMed] [Google Scholar]
  18. Petrali E. H., Sulakhe P. V. Calcium ion stimulated protein kinases in myelin. Prog Brain Res. 1982;56:125–144. doi: 10.1016/S0079-6123(08)63772-3. [DOI] [PubMed] [Google Scholar]
  19. Raff M. C., Miller R. H., Noble M. A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium. Nature. 1983 Jun 2;303(5916):390–396. doi: 10.1038/303390a0. [DOI] [PubMed] [Google Scholar]
  20. Ranscht B., Clapshaw P. A., Price J., Noble M., Seifert W. Development of oligodendrocytes and Schwann cells studied with a monoclonal antibody against galactocerebroside. Proc Natl Acad Sci U S A. 1982 Apr;79(8):2709–2713. doi: 10.1073/pnas.79.8.2709. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Sanders M. E., Koski C. L., Robbins D., Shin M. L., Frank M. M., Joiner K. A. Activated terminal complement in cerebrospinal fluid in Guillain-Barré syndrome and multiple sclerosis. J Immunol. 1986 Jun 15;136(12):4456–4459. [PubMed] [Google Scholar]
  22. Schlaepfer W. W. Vesicular disruption of myelin simulated by exposure of nerve to calcium ionophore. Nature. 1977 Feb 24;265(5596):734–736. doi: 10.1038/265734a0. [DOI] [PubMed] [Google Scholar]
  23. Scolding N. J., Frith S., Linington C., Morgan B. P., Campbell A. K., Compston D. A. Myelin-oligodendrocyte glycoprotein (MOG) is a surface marker of oligodendrocyte maturation. J Neuroimmunol. 1989 May;22(3):169–176. doi: 10.1016/0165-5728(89)90014-3. [DOI] [PubMed] [Google Scholar]
  24. Scolding N. J., Morgan B. P., Houston A., Campbell A. K., Linington C., Compston D. A. Normal rat serum cytotoxicity against syngeneic oligodendrocytes. Complement activation and attack in the absence of anti-myelin antibodies. J Neurol Sci. 1989 Feb;89(2-3):289–300. doi: 10.1016/0022-510x(89)90030-0. [DOI] [PubMed] [Google Scholar]
  25. Seeger W., Suttorp N., Hellwig A., Bhakdi S. Noncytolytic terminal complement complexes may serve as calcium gates to elicit leukotriene B4 generation in human polymorphonuclear leukocytes. J Immunol. 1986 Aug 15;137(4):1286–1293. [PubMed] [Google Scholar]
  26. Shirazi Y., Imagawa D. K., Shin M. L. Release of leukotriene B4 from sublethally injured oligodendrocytes by terminal complement complexes. J Neurochem. 1987 Jan;48(1):271–278. doi: 10.1111/j.1471-4159.1987.tb13158.x. [DOI] [PubMed] [Google Scholar]
  27. Sims P. J., Wiedmer T. Repolarization of the membrane potential of blood platelets after complement damage: evidence for a Ca++ -dependent exocytotic elimination of C5b-9 pores. Blood. 1986 Aug;68(2):556–561. [PubMed] [Google Scholar]
  28. Smith K. J., Hall S. M. Peripheral demyelination and remyelination initiated by the calcium-selective ionophore ionomycin: in vivo observations. J Neurol Sci. 1988 Jan;83(1):37–53. doi: 10.1016/0022-510x(88)90018-4. [DOI] [PubMed] [Google Scholar]
  29. Toews A. D., Fischer H. R., Goodrum J. F., Windes S., Morell P. Metabolism of phosphate and sulfate groups modifying the P0 protein of peripheral nervous system myelin. J Neurochem. 1987 Mar;48(3):883–887. doi: 10.1111/j.1471-4159.1987.tb05599.x. [DOI] [PubMed] [Google Scholar]
  30. Vanguri P., Shin M. L. Hydrolysis of myelin basic protein in human myelin by terminal complement complexes. J Biol Chem. 1988 May 25;263(15):7228–7234. [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES